Physician profile
Georgia Cassedy
NPI 1215771282
$1,916.14
in general payments reported to CMS, 2019-2025
12 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what 99% of School (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $652 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,916.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $375.00 | 2024 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $268.11 | 2024-2025 | Airsupra, Farxiga |
| Amgen INC. | $220.26 | 2025 | Krystexxa, Uplizna |
| Actelion Pharmaceuticals US, INC. | $215.00 | 2025 | Uptravi, Opsumit |
| Alexion Pharmaceuticals, INC. | $205.04 | 2024-2025 | Strensiq |
| Gilead Sciences, INC. | $128.33 | 2025 | |
| Kyowa Kirin, INC. | $125.71 | 2025 | |
| Phathom Pharmaceuticals, INC. | $123.30 | 2025 | Voquezna |
| Pfizer INC. | $122.26 | 2025 | |
| Axsome Therapeutics, INC. | $58.87 | 2025 | Auvelity |
| Hologic Sales and Service, LLC | $55.20 | 2025 | Aptima |
| Abbvie INC. | $19.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgia Cassedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.